Automated description from the Alliance of Genome Resources (Release 7.0.0)
Predicted to enable ubiquitin ligase-substrate adaptor activity. Acts upstream of or within fat cell differentiation and innate immune response. Predicted to be part of SCF ubiquitin ligase complex. Predicted to be active in cytoplasm. Is expressed in cranial ganglion; dorsal root ganglion; and liver. Orthologous to human FBXO9 (F-box protein 9).